Seattle Genetics pulls out of $2 billion bid for cancer drug

Bothell-based Seattle Genetics, the region’s biggest biotech firm, spiked a $2 billion deal to manfuacture and distribute an experimental tumor fighting drug.

The company announced in February that it had reached a deal with New Jersey-based Immunomedics for exclusive worldwide rights to develop IMMU-132, which could fight tumors in breast, lung and bladder cancers. Seattle Genetics agreed to pay $250 million upfront, with licensing payments potentially reaching as much as $2 billion.

A large shareholder in Immunomedics, venBio Select Advisor thought the deal undervalued the anti-cancer drug. In March, it filed a lawsuit to block the agreement.

Last week, shareholders led by venBio ousted the husband-and-wife team leading Immunomedics and approved a plan for the company to make and distribute IMMU-132.

The deal would be “nice to have,” but is “not a must have,” Seattle Genetics’ chief operating officer Eric Dobmeier said, according to Seeking Alpha, an investment news website.

Seattle Genetics has grown substantially in recent years, and expects to grow further in the next few years.

The company will focus its “full attention and resources to our promising pipeline and the substantial opportunities in front of us,” chief executive officer Clay Siegall said.

Its current product, Adcetris, could soon become a go-to drug for treating one of the main types of lymphoma. Seattle Genetics expects to bring several drugs to market in the next few years. The company plans to add 200 employees this year, raising its workforce to more than 1,100.

Dan Catchpole: 425-339-3454; dcatchpole@heraldnet.com; Twitter: @dcatchpole.

More in Business

Downtown Bothell cafes offer more than just coffee

From live music to gaming, offer entertainment as well as a caffeine fix.

Eastside tech companies Smartsheet, OfferUp, Apptio face challenging 2019

Here are a handful of companies from the Eastside that will be interesting to watch in 2019.

Northshore Fire job fair set for Jan. 30

More than 30 employers will be onsite for the event.

Tech set to continue driving Seattle-area housing market in 2019

A look at what’s the real estate market in the coming year.

‘This might have been a once in a generation opportunity’: Kenmore’s Lakepointe deal grinds to a halt

City officials unsure of what comes next for the more than 50 acre industrial site.

Jersey Mike’s opens in Bothell

The sandwich shop is holding a grand opening and free sandwich fundraiser from Nov. 14-18 to support the Northshore Schools Foundation.

Lakepointe is a 52-acre industrial site at the mouth of the Sammamish River and Lake Washington which the city of Kenmore has been hoping to see developed for nearly three decades. Aaron Kunkler/staff photo
Kenmore’s Lakepointe development talks collapse

A representative of the potential developer said it may be close to being dead.

Bothell’s smallest brewery earns “Best of Northshore” award

The micro-brewery has been pumping out the goods for more than eight years.

Store manager of the Bothell Helping Hands Thrift Store, Brittani Heitman, takes empty hangers to the back room to put more clothes onto the store floor. Madison Miller/staff photo.
Helping Hands Thrift Store serves locally and globally

The Bothell thrift store provides self-sustaining resources to Peru and local community.

Fall housing market shifts, but still seller’s market

Real estate snapshot for Bothell and Kenmore

Former Tully’s locations spring back to life

Following the coffee chain’s collapse earlier this year, other Eastside businesses are moving in.

Main Street in downtown Bothell reopened after a fire and construction in April. Evan Pappas/staff photo
Bothell Main Street business bouncing back after construction

After a fire and construction slowed business, many merchants are seeing people return.